Sigma-Tau unveils new pediatric probiotic
Refrigerated VSL#3 JUNIOR, available in a watermelon flavor, is gluten free and is comprised of eight strains of 225 billion live bacteria. Sigma-Tau Pharmaceuticals chief operating officer Dave
Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus (ocrelizumab) to treat multiple sclerosis (MS).